Viewing Study NCT00729612


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-26 @ 10:44 PM
Study NCT ID: NCT00729612
Status: COMPLETED
Last Update Posted: 2018-04-02
First Post: 2008-08-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Sponsor: Greg Otterson
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IIIB non-small cell lung cancer View
None stage IV non-small cell lung cancer View
None recurrent non-small cell lung cancer View
None squamous cell lung cancer View